Ver registro no DEDALUS
Exportar registro bibliográfico

Metrics


Metrics:

Galactosaemia in a brazilian population: high incidence and cost-benefit analysis (2009)

  • Authors:
  • USP affiliated authors: PASSADOR, CLAUDIA SOUZA - FEARP ; JORGE, SALIM MOYSÉS - FMRP ; CAMELO JUNIOR, JOSE SIMON - FMRP ; FERNANDES, MARIA INEZ MACHADO - FMRP ; MACIEL, LEA MARIA ZANINI - FMRP ; SCRIDELI, CARLOS ALBERTO - FMRP ; SANTOS, JAIR LICIO FERREIRA - FMRP ; CAMARGO JÚNIOR, ALCEU SALLES - FEA
  • USP Schools: FEARP; FMRP; FMRP; FMRP; FMRP; FMRP; FMRP; FEA
  • DOI: 10.1007/s10545-009-1112-1
  • Subjects: ERROS INATOS DO METABOLISMO; RECÉM-NASCIDO
  • Language: Inglês
  • Imprenta:
  • Source:
  • Acesso online ao documento

    DOI or search this record in
    Informações sobre o DOI: 10.1007/s10545-009-1112-1 (Fonte: oaDOI API)
    • Este periódico é de assinatura
    • Este artigo NÃO é de acesso aberto
    • Cor do Acesso Aberto: closed
    Informações sobre o Citescore
  • Título: Journal of Inherited Metabolic Disease

    ISSN: 0141-8955

    Citescore - 2017: 3.3

    SJR - 2017: 1.668

    SNIP - 2017: 1.398


  • Exemplares físicos disponíveis nas Bibliotecas da USP
    BibliotecaCód. de barrasNúm. de chamada
    FMRP11200054226-Spcd 1769344
    How to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas

    • ABNT

      CAMELO JÚNIOR, José Simon; FERNANDES, Maria Inez Machado; MACIEL, Léa Maria Zanini; et al. Galactosaemia in a brazilian population: high incidence and cost-benefit analysis. Journal of Inherited Metabolic Disease, Dordrecht, 2009. DOI: 10.1007/s10545-009-1112-1.
    • APA

      Camelo Júnior, J. S., Fernandes, M. I. M., Maciel, L. M. Z., Scrideli, C. A., Santos, J. L. F., Camargo Junior, A. S., et al. (2009). Galactosaemia in a brazilian population: high incidence and cost-benefit analysis. Journal of Inherited Metabolic Disease. doi:10.1007/s10545-009-1112-1
    • NLM

      Camelo Júnior JS, Fernandes MIM, Maciel LMZ, Scrideli CA, Santos JLF, Camargo Junior AS, Passador CS, Leite PC, Resende DR, Souza L de O, Giugliani R, Jorge SM. Galactosaemia in a brazilian population: high incidence and cost-benefit analysis. Journal of Inherited Metabolic Disease. 2009 ;
    • Vancouver

      Camelo Júnior JS, Fernandes MIM, Maciel LMZ, Scrideli CA, Santos JLF, Camargo Junior AS, Passador CS, Leite PC, Resende DR, Souza L de O, Giugliani R, Jorge SM. Galactosaemia in a brazilian population: high incidence and cost-benefit analysis. Journal of Inherited Metabolic Disease. 2009 ;

    Referências citadas na obra
    Applegarth DA, Toone JR, Lowry RB (2000) Incidence of inborn errors of metabolism in British Columbia, 1969–1996. Pediatrics 105(1): e10. doi: 10.1542/peds.105.1.e10
    ARUP Laboratories (2008) ARUP Online Scientific Resource, The University of Utah, Available at: http://www.arup.utah.edu/database/galactosemia/GALT_display.php . Last update: August 2008. Accessed September, 2008
    Bachmann C, Colombo J-P (1982) Incidence of disorders tested by systematic screening: confidence limits and comparison of programmes. J Inherit Metab Dis 5:3–5. doi: 10.1007/BF01799746
    Berry TG, Segal S, Gitzelmann R (2006) Disorders of galactose metabolism. In: Fernandes J, Saudubray J-M, van den Berghe G, Walter JH, eds. Inborn Metabolic Diseases—Diagnosis and Treatment. Heidelberg: Springer M. Verlag; 121–130
    Beutler E, Baluda M, Donnel GN (1964) A new method for the detection of galactosemia and its carrier state. J Lab Clin Med 64: 694–705
    Bosch AM (2006) Classical galactosaemia revisited. J Inherit Metab Dis 29: 516–525. doi: 10.1007/s10545–006–0382–0
    Bosch AM, Bakker HD, Wenniger-Prick L J M de B, et al (2004a) High tolerance for oral galactose in classical galactosaemia: dietary implications. Arch Dis Chil 89: 1034–1036. doi: 10.1136/adc.2003.037671
    Bosch AM, Grootenhuis MA, Bakker HD, et al (2004b) Living with classical galactosemia: health-related quality of life consequences. Pediatrics 113: e423. doi: 10.1542/peds.113.5.e423
    Brosnan CA, Swint JM (2001) Cost analysis: concepts and application. Public Health Nurs 18: 13–18. doi: 10.1046/j.1525–1446.2001.00013.x
    Calderon FRO, Phansalkar AR, Crokett DK, et al (2007) Mutation database for the galactose-1-phosphate uridyltransferase (GALT) Gene. Hum Mutat 28: 939–943. doi: 10.1002/humu.20544
    Canadian Organization for Rare Diseases/National Newborn Screening and Genetics Resource Center (2008) Canada Status Report, Austin, TX, USA. Updated 07/09/2008. Available at: http://genes-r-us.uthscsa.edu/CA_nbsdisorders.pdf . Accessed September 2008
    Clarke JTR (2006) Acute metabolic illness in the newborn. A Clinical Guide to Inherited Metabolic Diseases. 3rd edn. Cambridge: Cambridge University Press; 198–227
    Dahlqvist A (1971) A fluorometric method for the assay of galactose-1-phosphate in red blood cells. J Lab Clin Med 78: 931–938
    Davis JP, Eisenhardt KM, Bingham CB (2007) Developing theory through simulation methods. Acad Manage Rev 32: 480–499
    Diepenbrock F, Heckler R, Schickling H, et al (1992) Colorimetric determination of galactose and galactose-1-phosphate from dried blood. Clin Biochem 25: 37–39. doi: 10.1016/0009–9120(92)80043-G
    Elsas LJ (2007) Galactosemia. Gene Reviews. NIH, University of Washington, Seattle. Available at: http://www.genetests.org/profiles/galactosemia , Last Update: September 27, 2007. Accessed September, 2008
    Elsas LJ, Langley S, Steele E, et al (1995) Galactosemia: a strategy to identify new biochemical phenotypes and molecular genotypes. Am J Hum Genet 56: 630–639
    Hanley WB (2005) Newborn screening in Canada—are we out of step? Paediatr Child Health 10: 203–207
    Henderson H, Leisegang F, Brown R, et al (2002) The clinical and molecular spectrum of galactosemia in patients from the Cape Town region of South Africa. BMC Pediatrics 2: 7–12. doi: 10.1186/1471–2431–2–7
    Holton J, Walter J, Tyfield L (2001) Galactosemia. In: Scriver CR, Beaudet AL, Sly WS, Valle D, eds; Childs B, Kinzler kKW, Vogelstein B, assoc. eds. The Metabolic and Molecular Bases of Inherited Disease. 8th edn. New York: McGraw-Hill; 1553–1587
    Item C, Hagerty BP, Mühl A, et al (2002) Mutations at the galactose-1-P-uridyltransferase gene in infants with a positive galactosemia newborn screening test. Pediatr Res 51: 511–516. doi: 10.1203/00006450–200204000–00018
    Kwon C, Farrell P (2000) The magnitude and challenge of false positive newborn screening test results. Arch Pediatr Adolesc Med 154(7):714–718
    Lai K, Langley SD, Singh R, et al (1996) A prevalent mutation for galactosemia among black Americans. J Pediatr 128: 89–95. doi: 10.1016/S0022–3476(96)70432–8
    Loeber JG (2007) Neonatal screening in Europe: the situation in 2004. J Inherit Metab Dis 30: 430–438. doi: 10.1007/s10545–007–0644–5
    Manga N, Jenkins T, Jackson H, et al (1999) The molecular basis of transferase galactosaemia in South African negroids. J Inherit Metab Dis 22: 37–42. doi: 10.1023/A:1005491014280
    National Newborn Screening and Genetics Resource Center (2008) National Newborn Screening Status Report, Austin, TX, USA. Updated 08/07/2008. Available at: http://genes-r-us.uthscsa.edu/nbsdisorders.pdf . Accessed September 2008
    Ng WG, Xu YK, Wong LJ, et al (2003) Two adult galactosaemia females with normal ovarian function and identical GALT mutations (Q188R/R333G). J Inherit Metab Dis 26: 75–79. doi: 10.1023/A:1024039916476
    Odièvre M (2002) Le traitement de la galactosémie: de nouvelles stratégies? Arch Pédiatr 9: 563–565. doi: 10.1016/S0929–693X(01)00921–6
    Padilla CD, Dans LF, Estrada SC, et al (2003) Cost-benefit analysis of newborn screening for galactosemia in the Philippines. Southeast Asian J Trop Med Public Health 34(Supplement 3): 215–220
    Panis B, Bakker JA, Sels J-PJE, et al (2006) Untreated classical galactosemia patient with mild phenotype. Mol Genet Metabol 89: 277–279. doi: 10.1016/j.ymgme.2006.03.002
    Pollitt RJ, Green A, Mc Cabe CJ, et al (1997a) Neonatal screening for inborn errors of metabolism: cost, yield and outcome. Health Technol Assessment 1(7): 1–iv, 1–202. [Chapter 8. Diseases with existing stand-alone screens: 49–65]
    Pollitt RJ, Green A, Mc Cabe CJ, et al (1997b) Neonatal screening for inborn errors of metabolism: cost, yield and outcome. Health Technol Assessment 1(7): 1–iv, 1–202. [Chapter 17. Criteria for neonatal screening: evaluation from evidence in the literature: 137–140]
    Potter NL, Lazarus J-AC, Johnson JM, et al (2008) Correlates of language impairment in children with galactosaemia. J Inherit Metab Dis 31: 524–532. doi: 10.1007/s10545–008–0877-y
    Schulpis K, Papakonstantinou ED, Michelakakis H, et al (1997) Screening for galactosaemia in Greece. Pediatr Perinat Epidemiol 11: 436–440. doi: 10.1046/j.1365–3016.1997.d01–31.x
    Schweitzer-Krantz S (2003) Early diagnosis of inherited metabolic disorders towards improving outcome: the controversial issue of galactosaemia. Eur J Pediatr 162: S50–53. doi: 10.1007/s00431–003–1352–2
    SEADE (2007) Fundação Sistema Estadual de Análise de Dados, São Paulo, Brasil. Population divided by gender, race/ethnicity, São Paulo State, Brazil, 2004. Available at: http://www.seade.gov.br/produtos/idr/dem/dem_pop_03.htm . Accessed September, 2008
    Segal S (2006) Of mice and men: Galactosemia. Mol Genet Metabol 89: 401–402. doi: 10.1016/j.ymgme.2006.06.005
    Tyfield LA (2000) Galactosemia and allelic variation at the galactose-1-phosphate uridyltransferase gene: a complex relationship between genotype and phenotype. Eur J Pediatr 159: S204–207. doi: 10.1007/PL00014404
    Tyfield L, Reichardt J, Fridovich-Keil J, et al (1999) Classical galactosemia and mutations at the galactose-1-phosphate uridyl transferase (GALT) gene. Hum Mutat 13: 417–430. doi: 10.1002/(SICI)1098–1004(1999)13:6<417::AID-HUMU1>3.0.CO;2–0
    Waisbren SE, Read CY, Ampola M, et al for the New England Consortium of Metabolic Programs (2002) Newborn screening compared to clinical identification of biochemical genetic disorders. J Inherit Metab Dis 25: 599–600. doi: 10.1023/A:1022003726224
    Walter JH (2003) Arguments for early screening: a clinician’s perspective. Eur J Pediatr 162(Supplement 1): S2–4
    WHO (2000): Assessing New Vaccines for National Immunization Programmes – A Framework to Assist Decision Makers. Immunization Focus. World Health Organization. Regional Office for the Western Pacific. Manila, ISBN: 92 9061 154 5). Available at: http://www.wpro.who.int/NR/rdonlyres/280FF00E-D121–4C40-A41F-F55D0B08F61A/0/assessing_new_vaccines.pdf . Accessed February, 2009)
    Yang Y-P, Corley N, Garcia-Heras J (2002) Molecular analysis in newborns from Texas affected with galactosemia. Hum Mutat 19: 82–83. doi: 10.1002/humu.9005